Lexeo Therapeutics Inc. C... (LXEO)
NASDAQ: LXEO
· Real-Time Price · USD
4.71
-0.08 (-1.67%)
At close: Aug 15, 2025, 3:59 PM
4.72
0.21%
After-hours: Aug 15, 2025, 05:36 PM EDT
Lexeo Therapeutics Common Stock Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
Net Income | -109.31M | -98.33M | -86.6M | -77.22M | -69.42M | -66.39M | -66.78M | -63.73M | -65.43M | -59.28M | -44.7M | -27.64M | -12.5M |
Depreciation & Amortization | 346K | 750K | 719K | 1.92M | 1.87M | 1.84M | 1.8M | 1.68M | 1.59M | 1.15M | 700K | 358K | 6.7K |
Stock-Based Compensation | 13.84M | 12.47M | 9.77M | 6.85M | 4.98M | 3.04M | 2.76M | 2.32M | 1.35M | 952K | 431K | n/a | n/a |
Other Working Capital | -10.57M | -8.79M | -6.16M | 2.58M | 6.64M | 1.66M | 1.61M | 1.84M | 3.45M | 2.27M | 4.07M | -428K | -2.78M |
Other Non-Cash Items | 10.38M | 10.37M | 10.65M | 530K | 530K | 530K | 272K | n/a | 554.11K | 828.83K | 828.83K | 828.83K | 274.72K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -3.69M | -6.41M | -1.35M | 4.96M | 6.05M | 1.48M | -187K | -248K | 4.1M | 1.79M | 4.81M | 313K | -2.87M |
Operating Cash Flow | -88M | -81.15M | -66.81M | -62.95M | -55.99M | -59.5M | -62.14M | -59.98M | -57.84M | -54.56M | -37.93M | -26.14M | -15.09M |
Capital Expenditures | -275K | -468K | -554K | -537K | -358K | -165K | -199K | -546K | -727.38K | -901K | -794K | -394K | -173.63K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 15.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -93.6M | -93.61M | -26K | -63K | -58K | -50K | -132K | -126K | -126K | -126K | -44K | n/a | n/a |
Investing Cash Flow | -78.28M | -94.08M | -567K | -537K | -358K | -165K | -199K | -546K | -727.38K | -901K | -794K | -394K | -173.63K |
Debt Repayment | -460K | -410K | -399K | 3.6M | 3.58M | 3.58M | 3.57M | -357K | -254K | -144K | -36K | n/a | n/a |
Common Stock Repurchased | -4K | -4K | n/a | -13K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 481K | 491K | 100.64M | 100.62M | 100.21M | 100.22M | 68K | 49K | 89.01K | 333K | 305K | 305K | 255.99K |
Financial Cash Flow | 133K | 88.78M | 188.94M | 192.93M | 192.54M | 103.79M | 3.64M | -308K | -164.99K | 189K | 270K | 305K | 255.99K |
Net Cash Flow | -162.9M | -83.2M | 124.82M | 132.69M | 136.2M | 44.13M | -58.7M | -64.09M | -58.73M | -55.27M | -38.46M | -26.23M | -15.01M |
Free Cash Flow | -88.28M | -81.62M | -67.36M | -63.49M | -56.35M | -59.66M | -62.34M | -60.53M | -58.57M | -55.46M | -38.73M | -26.54M | -15.27M |